ASCB Member Survey on Reproducibility

Similar documents
An Overview of Cells and Cell Research

Basic Biological Principles Module A Anchor 1

M The Nucleus M The Cytoskeleton M Cell Structure and Dynamics

MEDICAL LABORATORY TECHNICIAN COMPETENCY PROFILE

Subject Coverage Read and see these newly featured protocols online at

UPBM CURRICULAR BROCHURE

But what about the prokaryotic cells?

Biology M.S. and Ph.D. Programs

Enter this essay in the English Language Learner (for 5 years or less of English) category: _X_ Yes

MOLECULAR PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Operational Definition for Evidence-Based Practices Addictions and Mental Health Division September 11, 2007

COURSE SYLLABUS BIOL 1010 Introduction to Biology I (4)

What do Birmingham postgraduates do?

SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS

2015 UW-IT Customer Experience Survey

Biology 156 Introductory Biology for Allied Health Professor: Darin Taverna, PhD

Preliminary DS-2019 Checklist

Installation and Operational Qualification Protocol (Reference: SOP )

G&D. apoptosis, tumor suppressor and cell cycle research antibodies. 3 a A JOURNAL OF CELLULAR AND MOLECULAR BIOLOGY

Master's Degree Programme in Biotechnology (MBIOT)

Combining Science with Business in a Large Biotech Setting


Given these characteristics of life, which of the following objects is considered a living organism? W. X. Y. Z.

UNIVERSITY OF COLORADO BOULDER FRINGE BENEFIT RATES BY JOB CODES FISCAL YEAR 2017

Recombinant DNA and Biotechnology

How Can Institutions Foster OMICS Research While Protecting Patients?

University of Houston. Research Pay Plan

Gerrit Rietveld Academie. Report Survey Housing and Safety

Bioethics Education in Professional Science Master s Programs at California State University Channel Islands

The need for longitudinal study of the dual roles of insects as pests and food resources in agroecosystems

PRE-TEST/POST-TEST FOR THE RESEARCH ETHICS TRAINING CURRICULUM. Please indicate if the following statements are True (T) or False (F).

Cell Division Simulation: Bacteria Activity One

PHYSIOLOGY. THE STUDY OF LIFE, and how genes, cells, tissues, and organisms function.

UT Health Science Center at San Antonio Research/Grant Records

New Scientist/SRG Salary Survey 2013

TECHNICAL SUPPORT. and HARDWARE/SOFTWARE/NETWORK MAINTENANCE. for DIAMOND SERVER

CHMP/BWP (COMMITTEE ABBREVIATION) GUIDELINE ON VIRUS SAFETY EVALUATION OF BIOTECHNOLOGICAL INVESTIGATIONAL MEDICINAL PRODUCTS

Department of Biochemistry & Molecular Biology Strategic Planning Phase III Part II: Research and Graduate Education

Microbiology and Auditing. Don Singer

Bacterial Transformation Post lab Questions:

How Does a Doctor Test for AIDS?

Q1 ROUTINE APPOINTMENTS Did you see the GP of your choice today?

Cytel au service des maladies rares : exemple d un partenariat réussi

INTERNATIONALE STICHTING ALZHEIMER ONDERZOEK APPLICATION FELLOWSHIP VISITING PROFESSOR / SENIOR SCIENTIST. GUIDELINES and INSTRUCTIONS

PEOPLE > SCIENCE > SOLUTIONS

Introduction To Epigenetic Regulation: How Can The Epigenomics Core Services Help Your Research? Maria (Ken) Figueroa, M.D. Core Scientific Director

TEACHING POSITIONS AVAILABLE IN BIOLOGY UNIVERSITY OF SAN FRANCISCO SPRING 2014

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

1 Mutation and Genetic Change

General Response Rates

Course Certificate In. Pharmaceuticals and Medical Research: Clinical Research Monitoring & Coordination

Caltech Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern

Preparing for Graduate School in Biology and Related Fields

Powering Cutting Edge Research in Life Sciences with High Performance Computing

University of Illinois at Chicago

Guide to Cover Letters

Fact Book Compiled by the Office of Institutional Research

Multimedia & the World Wide Web

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

Quality Monitoring Checklist

Never want to leave college?

Careers in Neuroscience / Career Paths: Academic Research

GENETICS (BIO240) Syllabus

Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)

BERKELEY CITY COLLEGE COLLEGE OF ALAMEDA LANEY COLLEGE MERRITT COLLEGE

Quick Hit Activity Using UIL Science Contests For Formative and Summative Assessments of Pre-AP and AP Biology Students

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

Descriptive Inferential. The First Measured Century. Statistics. Statistics. We will focus on two types of statistical applications

Biology for the Nanotechnology Classroom. Erinn Mee 10/9/2015

Health Care Job Information Sheet #20. Clinical Research

Archimedes Principle. Biological Systems

Biotechnology Programs. Biotechnology Associate in Science Degree

McDonough School of Business: MSBTC SLA 2014

Careers in Lab Sciences. A Student s Guide to Finding a Career Pathway with a Degree in Biology

Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry

CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire

BYOD and IT Service Management: what is the likely impact?

A Degree in Science is:

Graduate Fellowships. Preparing the leaders of tomorrow. school of medicine. The Campaign for Washington University

Radiation Center Space Allocation Policy

Trasposable elements: P elements

Crossing the drug development divide

* For additional information please refer to the Graduate Handbook.

Research Methods & Experimental Design

TRAINING SCHOOL IN EXPERIMENTAL DESIGN & STATISTICAL ANALYSIS OF BIOMEDICAL EXPERIMENTS

Laney Information Technology Services

Society of Wetland Scientists Professional Certification Program Certification Renewal Form Application Information

Christine M. Cunningham Associate Professor New York Chiropractic College 2360 Route 89 Seneca Falls, New York

Focus on Your Future: PhD and MD-PhD Programs and Research Careers

PATHOLOGY. HercepTestTM. Product Information

The Way Forward McGill & Food Safety

The Center for Clinical Simulation. An experiential learning environment for transformational nursing education

Funding Opportunities Starter Grants

LEADERSHIP DEVELOPMENT

Free to Breathe 2015 Research Grant To Prevent or Stop Lung Cancer Metastasis. Request for Proposals

Multiple Myeloma Research Foundation Research Fellow Award. Program Guidelines

MONOCLONAL ANTIBODIES

Survey of DC pension scheme members

ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare

Lab: Graphing Activities TOTTEN

Transcription:

Q1 What best describes your position? (Choose one): Answ ered: 869 Skipped: 3 Graduate Student Postdoctoral Fellow Faculty member/pi Scientist in industry/bio... Gov ernment Scientist Other (please specify) Graduate Student Postdoctoral Fellow Faculty member/pi Scientist in industry/biotechnology Government Scientist Other (please specify) 11.51% 100 15.77% 137 63.64% 553 2.53% 22 2.65% 23 3.91% 34 Total 869 # Other (please specify) Date 1 Professor emeritus 7/29/2014 2:52 PM 2 Retired government scientist 7/29/2014 2:20 PM 3 Retired Government Scientist 7/13/2014 4:14 AM 4 research scientist 7/5/2014 3:52 PM 5 Postdoctoral associate 7/2/2014 5:12 PM 6 Unemployed pharmaceutical scientist 7/1/2014 9:34 PM 7 research faculty 7/1/2014 6:37 PM 8 Research Technician at University 7/1/2014 3:22 PM 9 Academic research scientist/lab manager 7/1/2014 10:33 AM 10 Sr. Research Fellow 7/1/2014 8:26 AM 11 staff scientist 7/1/2014 4:12 AM 12 Facility Manager Microscopy 7/1/2014 2:30 AM 13 research scientist (beyond postdoc, academic) 6/30/2014 8:49 PM 14 scientist in research institute 6/30/2014 6:54 PM 15 research staff scientist 6/30/2014 5:46 PM 16 Professor emeritus 6/30/2014 5:30 PM 17 Scientist in non-profit organization 6/30/2014 4:53 PM 18 retired research faculty 6/30/2014 4:40 PM 19 Government Fellow 6/30/2014 4:39 PM 20 staff scientist 6/30/2014 4:36 PM 1 / 32

21 Science writer; former academic scientist (therefore, answers below are from most recent lab position) 6/30/2014 4:30 PM 22 research associate 6/30/2014 4:04 PM 23 research scientist in education/government 6/30/2014 3:59 PM 24 research scientist 6/30/2014 3:57 PM 25 Facility Manager 6/30/2014 3:55 PM 26 research scientist 6/30/2014 3:44 PM 27 Director, Microscopy Center 6/30/2014 3:32 PM 28 research scientist at university medical school 6/30/2014 3:31 PM 29 Clinical Research Scientist 6/30/2014 3:31 PM 30 Lab Manager 6/30/2014 3:29 PM 31 Professor at PUI 6/30/2014 3:26 PM 32 Assoc. Vice President for Research @ university 6/30/2014 3:23 PM 33 Research Associate 6/30/2014 3:19 PM 34 Technician at Universtiy 6/30/2014 3:13 PM 2 / 32

Q2 Which model systems do you use? (Choose all the apply): Answ ered: 868 Skipped: 4 Virus & host cells Bacteria Yeast/Fungi Other microbial... C. elegans Drosophila Xenopus Mice/Rats Plants Tissue culture cells Other Virus & host cells Bacteria Yeast/Fungi Other microbial eukaryotes C. elegans Drosophila Xenopus Mice/Rats Plants Tissue culture cells Other 10.71% 93 17.86% 155 19.47% 169 5.88% 51 5.65% 49 7.26% 63 5.07% 44 37.10% 322 2.42% 21 70.16% 609 10.48% 91 Total Respondents: 868 3 / 32

Q3 Have you ever been unable to replicate a published experimental result? Answ ered: 868 Skipped: 4 Yes No Yes No 71.54% 621 28.46% 247 Total 868 4 / 32

Q4 Has another laboratory ever told you that they have had trouble replicating one of your published experimental results? Answ ered: 868 Skipped: 4 Yes No Yes No 22.81% 198 77.19% 670 Total 868 5 / 32

Q5 Thinking of the instance that led to you answer yes above, how was the issue resolved? Answ ered: 597 Skipped: 275 Resolv ed myself w ith... Resolv ed amicably by... Resolv ed upon contentious... Resolution occurred, bu... Unresolv ed Resolved myself with additional trials Resolved amicably by consulting with the other lab Resolved upon contentious consultation with the other lab Resolution occurred, but not via reproduction. A better technology or different approach was used to resolve the issue. Unresolved 15.75% 94 16.25% 97 3.02% 18 25.29% 151 39.70% 237 Total 597 6 / 32

Q6 If unresolved, why not? Answ ered: 284 Skipped: 588 Unresolv ed despite... Unresolv ed in the face of... Unresolv ed because the... Unresolved despite amicable consultation with the other lab Unresolved in the face of contentious consultation with the other lab Unresolved because the issue was deemed not important enough to pursue 27.82% 79 16.90% 48 55.28% 157 Total 284 7 / 32

Q7 If the discrepancy is resolved, what were the key issues in resolving the issue? (Choose all the apply) Answ ered: 417 Skipped: 455 The original result w as a... Lack of appropriate... Incomplete specificatio... Failure to follow the... Differences in Biological... RNAi complications Reagents (including... Detection method (e.g... Lack of rigorous... Low powered replication... Random error The original result was a false positive Lack of appropriate expertise or rigor Incomplete specification of original protocol could not accurately guide the replication attempt Failure to follow the original protocol Differences in Biological strains/genetic background RNAi complications Reagents (including antibodies, sera, plasmids, etc.) Detection method (e.g. sensitivity of different instruments, cameras or assays) Lack of rigorous statistical analysis Low powered replication methods Random error 22.78% 95 40.05% 167 45.32% 189 15.35% 64 24.70% 103 5.04% 21 37.65% 157 25.90% 108 8.87% 37 6.95% 29 5.76% 24 Total Respondents: 417 8 / 32

Q8 If the discrepancy is resolved, how much time and effort did it take to resolve the issue. Answ ered: 416 Skipped: 456 Huge amount of time Significant amount of time Some time Very little time No time at all Huge amount of time Significant amount of time Some time Very little time No time at all 11.54% 48 42.79% 178 38.94% 162 5.77% 24 0.96% 4 Total 416 9 / 32

Q9 What factors do you believe contribute to poor reproducibility? Answ ered: 866 Skipped: 6 Poor laboratory... Lack of resources to... Pressure to publish in a... Poor methodologic... Poor statistical... 0 1 2 3 4 5 Strongly Disagree Disagree Neither Agree or Disagree Agree Strongly Agree Total Av erage Rating Poor laboratory record keeping 2.51% 21 11.12% 93 23.44% 196 48.21% 403 14.71% 123 836 3.61 Lack of resources to appropriately executive the experiments 6.91% 57 22.18% 183 31.76% 262 30.06% 248 9.09% 75 825 3.12 Pressure to publish in a high profile journal 2.36% 20 6.37% 54 14.50% 123 37.50% 318 39.27% 333 848 4.05 Poor methodological training 1.53% 13 7.78% 66 19.34% 164 50.12% 425 21.23% 180 848 3.82 Poor statistical knowledge 3.85% 32 13.12% 109 25.15% 209 40.91% 340 16.97% 141 831 3.54 10 / 32

Q10 Based on your knowledge of failures to replicate published results, rate the extent to which each of the following plays a role in the failure to replicate: Answ ered: 846 Skipped: 26 The original result w as a... Lack of appropriate... Lack of appropriate... Incomplete specificatio... Failure to follow the... Differences in Biological... RNAi complications Reagents (including... Detection method (e.g... Lack of rigorous... Low powered replication... Random error 0 1 2 3 4 5 Strongly Disagree Disagree Neither Agree or Disagree Agree Strongly Agree Total Av erage Rating The original result was a false positive 3.29% 27 11.69% 96 33.62% 276 40.80% 335 10.60% 87 821 3.44 Lack of appropriate expertise or rigor among the team making the original observation 1.20% 10 6.82% 57 22.73% 190 50.84% 425 18.42% 154 836 3.78 Lack of appropriate expertise or rigor among the replication team 5.12% 42 18.66% 153 34.88% 286 36.59% 300 4.76% 39 820 3.17 Incomplete specification of original protocol could not accurately guide the replication attempt 1.33% 11 5.69% 47 16.71% 138 43.83% 362 32.45% 268 826 4.00 Failure to follow the original protocol 4.91% 40 20.02% 163 33.17% 270 35.87% 292 6.02% 49 814 3.18 Differences in Biological strains/genetic background 3.30% 27 8.45% 69 26.93% 220 45.41% 371 15.91% 130 817 3.62 RNAi complications 4.33% 34 11.34% 89 58.09% 456 21.02% 165 5.22% 41 785 3.11 Reagents (including antibodies, sera, plasmids, etc.) 3.19% 26 8.70% 71 23.41% 191 51.23% 418 13.48% 110 816 3.63 Detection method (e.g. sensitivity of different instruments, cameras or assays) 3.07% 25 11.17% 91 30.92% 252 45.77% 373 9.08% 74 815 3.47 Lack of rigorous statistical analysis 3.71% 30 13.47% 109 34.61% 280 38.07% 308 10.14% 82 809 3.37 Low powered replication methods 11 / 32 4.03% 14.61% 42.70% 33.38% 5.29%

Low powered replication methods ASCB Member Survey on Reproducibility 4.03% 32 14.61% 116 42.70% 339 33.38% 265 5.29% 42 794 3.21 Random error 7.95% 63 20.20% 160 46.59% 369 22.98% 182 2.27% 18 792 2.91 12 / 32